Table 3 Bivariate results of receipt of type or class of antiretroviral therapy by recipient age, race/ethnicity, gender and geographic region (white and black non-Hispanic plus Hispanic Medicaid recipients, n = 7202)
(n)NRTI (%)NNRTI (%)PI (%)Combivir (%)Efavirenz (%)Any antiretroviral drug therapy (%)Multidrug therapy (at least two drugs in same year) (%)HAART (%)
Total72025297 (73.5)1771 (24.6)4452 (61.8)2101 (29.2)362 (5.0)5239 (72.7)5012 (69.6)4430 (61.5)
Age (years)
    <2016679 (47.6)13 (7.8)53 (31.9)29 (17.5)4 (2.4)80 (48.2)74 (44.6)56 (33.7)
    20–29767460 (60.0)129 (16.8)356 (46.4)208 (27.1)22 (2.9)465 (60.6)412 (53.7)356 (46.4)
    30–3928332109 (74.4)760 (26.8)1785 (63.0)778 (27.5)166 (5.9)2150 (75.9)2027 (71.5)1784 (63.0)
    40–4925551994 (78.0)667 (26.1)1699 (66.5)819 (32.1)139 (5.4)2013 (78.8)1880 (73.6)1683 (65.9)
    50–59752563 (74.9)181 (24.1)486 (64.6)229 (30.5)28 (3.7)568 (75.5)533 (70.9)481 (64.0)
    60+12992 (71.3)21 (16.3)73 (56.6)38 (29.5)3 (2.3)92 (71.3)86 (66.7)70 (54.3)
Race/ethnicity
    White NH26102077 (79.6)784 (30.0)1773 (67.9)657 (25.2)195 (7.5)2107 (80.7)2006 (76.9)1783 (68.3)
    Black NH42362978 (70.3)901 (21.3)2466 (58.2)1340 (31.6)153 (3.6)3017 (71.2)2777 (65.6)2436 (57.5)
    Hispanic356242 (68.0)86 (24.2)213 (59.8)104 (29.2)14 (3.9)244 (68.5)229 (64.3)211 (59.3)
Gender
    Male40113237 (80.7)1142 (28.5)2792 (69.6)1211 (30.2)244 (6.1)3283 (81.8)3110 (77.5)2778 (69.3)
    Female31912060 (64.6)629 (19.7)1660 (52.0)890 (27.9)118 (3.7)2085 (65.3)1902 (59.6)1652 (51.8)
Rural–urban
    Urban63484659 (73.4)1602 (25.2)3955 (62.3)1851 (29.2)324 (5.1)4724 (74.4)4424 (69.7)3919 (61.7)
    Rural854638 (74.7)169 (19.8)497 (58.2)250 (29.3)38 (4.4)644 (75.4)588 (68.9)511 (59.8)
State
    AR221168 (76.0)49 (22.2)133 (60.2)72 (32.6)9 (4.1)168 (76.0)151 (68.3)135 (61.1)
    GA19051165 (61.2)265 (13.9)892 (64.2)433 (22.7)54 (2.8)1179 (61.9)1063 (55.8)890 (46.7)
    IN664566 (85.2)206 (31.0)489 (73.6)204 (30.7)44 (6.6)581 (87.5)550 (82.8)477 (71.8)
    NJ34132618 (76.7)924 (27.1)2277 (66.7)1214 (35.6)166 (4.9)2644 (77.5)2479 (72.6)2259 (66.2)
    WA999780 (78.1)37 (32.7)661 (66.2)178 (17.8)89 (8.9)796 (79.7)769 (77.0)669 (67.0)
  • NRTI, nucleoside reverse transcriptase inhibitors; NNRTI, non-nucleoside reverse transcriptase inhibitors; PI protease inhibitors; AR, Arkansas; GA, Georgia; IN, Indiana; NJ, New Jersey; WA, Washington.